Real-World Strategies for Overcoming Disparities in Immunotherapy Cancer Care
Follow real-world patients on their cancer journeys as they and their multidisciplinary clinical teams navigate barriers to receive treatment with immunotherapy. Complementing these stories are insights from experts on the underlying issues fueling disparate access to immunotherapies as well as strategies to overcome treatment barriers for patients in under-resourced communities.
Help close persistent immunotherapy access gaps to ensure your patients receive the best possible care.
FACULTY
Narjust Duma, MD
Assistant Professor of Medicine
Harvard Medical School
Associate Director of The Cancer Care Equity Program
Thoracic Oncologist
Lowe Center For Thoracic Oncology
Dana-Farber Cancer Institute
Boston, MA
Lauren Gilson, BSN, RN
Oncology Nurse
Thomas Jefferson University Hospital
Philadelphia, PA
Jennifer Johnson, MD, PhD, FACP
Associate Professor
Department of Medical Oncology
Thomas Jefferson University
Philadelphia, PA
Ana Maria Lopez, MPH, MD, MPH, MACP, FRCP
Professor and Vice Chair, Medical Oncology
Sidney Kimmel Medical College
Chief of Cancer Services
Sidney Kimmel Cancer Center- Jefferson Health
Philadelphia, PA
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP
Clinical Professor of Medicine and Medical Oncology
Department of Medical Oncology
Director, Center to Eliminate Cancer Disparities
Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson
Philadelphia, PA
Mark S. Morginstin, DO
Medical Oncologist
Einstein Healthcare Network
Einstein Medical Center Montgomery
East Norriton, PA
Lora Rhodes, MSW, LCSW
Senior Social Worker
Sidney Kimmel Cancer Center
Thomas Jefferson University Hospital
Philadelphia, PA
Jermine Mousa, PharmD
Clinical Oncology Pharmacy Manager
Einstein Medical Center Montgomery
East Norriton, PA